Literature DB >> 11007230

Enterocolitis in children with developmental disorders.

A J Wakefield1, A Anthony, S H Murch, M Thomson, S M Montgomery, S Davies, J J O'Leary, M Berelowitz, J A Walker-Smith.   

Abstract

OBJECTIVE: Intestinal pathology, i.e., ileocolonic lymphoid nodular hyperplasia (LNH) and mucosal inflammation, has been described in children with developmental disorders. This study describes some of the endoscopic and pathological characteristics in a group of children with developmental disorders (affected children) that are associated with behavioral regression and bowel symptoms, and compares them with pediatric controls.
METHODS: Ileocolonoscopy and biopsy were performed on 60 affected children (median age 6 yr, range 3-16; 53 male). Developmental diagnoses were autism (50 patients), Asperger's syndrome (five), disintegrative disorder (two), attention deficit hyperactivity disorder (ADHD) (one), schizophrenia (one), and dyslexia (one). Severity of ileal LNH was graded (0-3) in both affected children and 37 developmentally normal controls (median age 11 yr, range 2-13 yr) who were investigated for possible inflammatory bowel disease (IBD). Tissue sections were reviewed by three pathologists and scored on a standard proforma. Data were compared with ileocolonic biopsies from 22 histologically normal children (controls) and 20 children with ulcerative colitis (UC), scored in an identical manner. Gut pathogens were sought routinely.
RESULTS: Ileal LNH was present in 54 of 58 (93%) affected children and in five of 35 (14.3%) controls (p < 0.001). Colonic LNH was present in 18 of 60 (30%) affected children and in two of 37 (5.4%) controls (p < 0.01). Histologically, reactive follicular hyperplasia was present in 46 of 52 (88.5%) ileal biopsies from affected children and in four of 14 (29%) with UC, but not in non-IBD controls (p < 0.01). Active ileitis was present in four of 51 (8%) affected children but not in controls. Chronic colitis was identified in 53 of 60 (88%) affected children compared with one of 22 (4.5%) controls and in 20 of 20 (100%) with UC. Scores of frequency and severity of inflammation were significantly greater in both affected children and those with UC, compared with controls (p < 0.001).
CONCLUSIONS: A new variant of inflammatory bowel disease is present in this group of children with developmental disorders.

Entities:  

Mesh:

Year:  2000        PMID: 11007230     DOI: 10.1111/j.1572-0241.2000.03248.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  41 in total

1.  New evidence for a viral pathogenic mechanism for new variant inflammatory bowel disease and development disorder?

Authors:  A Morris; D Aldulaimi
Journal:  Mol Pathol       Date:  2002-04

2.  Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine.

Authors:  B Thjodleifsson; K Davídsdóttir; U Agnarsson; G Sigthórsson; M Kjeld; I Bjarnason
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

3.  Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.

Authors:  Gehan A Mostafa; Laila Y Al-Ayadhi
Journal:  J Neuroinflammation       Date:  2011-04-25       Impact factor: 8.322

Review 4.  MMR vaccination and autism : what is the evidence for a causal association?

Authors:  Kreesten M Madsen; Mogens Vestergaard
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 5.  Microbe hunting.

Authors:  W Ian Lipkin
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

6.  Is there a 'regressive phenotype' of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study.

Authors:  Jennifer Richler; Rhiannon Luyster; Susan Risi; Wan-Ling Hsu; Geraldine Dawson; Raphael Bernier; Michelle Dunn; Susan Hepburn; Susan L Hyman; William M McMahon; Julie Goudie-Nice; Nancy Minshew; Sally Rogers; Marian Sigman; M Anne Spence; Wendy A Goldberg; Helen Tager-Flusberg; Fred R Volkmar; Catherine Lord
Journal:  J Autism Dev Disord       Date:  2006-04

7.  Measles-mumps-rubella vaccine and autistic spectrum disorder: A hypothesis only.

Authors: 
Journal:  Paediatr Child Health       Date:  2001-07       Impact factor: 2.253

Review 8.  Autistic enterocolitis: fact or fiction?

Authors:  Polymnia Galiatsatos; Adrian Gologan; Esther Lamoureux
Journal:  Can J Gastroenterol       Date:  2009-02       Impact factor: 3.522

9.  Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease.

Authors:  A J Russo; A Krigsman; B Jepson; Andrew Wakefield
Journal:  Biomark Insights       Date:  2009-11-27

10.  Low Serum Alpha-1 Antitrypsin (AAT) in Family Members of Individuals with Autism Correlates with PiMZ Genotype.

Authors:  Anthony J Russo; Lauren Neville; Christine Wroge
Journal:  Biomark Insights       Date:  2009-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.